Table 4.
P-score | |
---|---|
| |
Dupilumab | 0.83 |
Mepolizumab | 0.66 |
Reslizumab | 0.62 |
Benralizumab | 0.36 |
Placebo | 0.00 |
P-scores are based solely on the point estimates and standard errors of the network estimates
P-score | |
---|---|
| |
Dupilumab | 0.83 |
Mepolizumab | 0.66 |
Reslizumab | 0.62 |
Benralizumab | 0.36 |
Placebo | 0.00 |
P-scores are based solely on the point estimates and standard errors of the network estimates